Biofrontera AG Sponsored ADR - 48 Year Dividend History | BFRA

Historical dividend payout and yield for Biofrontera AG Sponsored ADR (BFRA) since 1971. The current TTM dividend payout for Biofrontera AG Sponsored ADR (BFRA) as of June 14, 2019 is $0.00. The current dividend yield for Biofrontera AG Sponsored ADR as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.375B $0.025B
Biofrontera AG is a biopharmaceutical company. It engaged in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases. The company's products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions which can sometimes lead to skin cancer as well as the treatment of certain forms of basal cell carcinoma in the European Union. Biofrontera AG is based in Leverkusen, Germany.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83